Savant Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,434
Closed -$135K 1935
2025
Q1
$135K Buy
+25,434
New +$135K ﹤0.01% 1474